MedPath

TARO-DASATINIB

TARO-DASATINIB

Approved
DIN Number

02499347

Drug Class

Human

Market Date

Mar 4, 2021

Company
HC

Taro Pharmaceuticals Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02499347
AIG Number0152198006
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01EA02 DASATINIB
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

DASATINIBActive
Strength: 140 MG
Monograph: DASATINIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.